ARTICLES BY THIS AUTHOR
- 3/26/2024
Amazon Pharmacy debuts same-day delivery in NYC, L.A.
Same-day delivery will expand to more than a dozen cities by the end of the year using environmentally friendly delivery vehicles, including e-bikes, electric vans and drones. - 3/25/2024
How collaboration and technology are improving health in communities
Panelists at DSN’s Industry Issues Summit discussed advances and innovations in improving community health. - 3/25/2024
Target reportedly doubling salaried employees' bonuses
Target is reportedly doubling bonuses for salaried employees, per a Bloomberg report. - 3/26/2024
Lupin obtains FDA nod for generic Abilify
Aripiprazole Tablets are indicated for the treatment of schizophrenia and the acute treatment of manic and mixed episodes associated with bipolar I disorder. - 3/22/2024
Watch DSN: HRG shares perspective on changing OTC formulations, products
Dave Wendland, vice president of strategic relations at Hamacher Resource Group, discusses how OTC manufacturers are becoming more intentional with their new product launches. - 3/22/2024
Industry Issues Summit: How VillageMD is transforming health care
A fireside chat at DSN’s Industry Issues Summit highlighted VillageMD’s focus on patient care. - 3/21/2024
PLMA, Store Brands announce The 2024 Private Label Hall of Fame inductees
The 2024 recipients consist of 16 individuals who are honored in four categories: lifetime achievement; private brand champion; private brand innovator; and next gen private label leader. - 3/28/2024
CVS Health intros CostVantage, TrueCost
Launching for commercials payors in 2025, CostVantage is intended to shift how CVS Health's pharmacies are compensated by payors. - 3/25/2024
Camber intros theophylline extended-release tablets
Theophylline ER tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases. - 3/25/2024
AAM: Avalere study shows PBMs continue to block patient access to biosimilars
The analysis reiterates that biosimilar challenges are not limited to the Humira market.